Daniel is a member of the Patents Technology & Life Sciences Practice Area. His practice focuses on advising and representing national and international pharmaceutical companies and medical device manufacturers, with a particular emphasis on drug advertising law and regulatory issues in the field of pharmaceutical and medical device law.
Higher Regional Court of Hamburg: On the risk classification of health apps
Higher Regional Court of Nuremberg: In principle, no loss of urgency due to the full utilisation of legal deadlines
par plusieurs auteurs
par Manon van Weezel et Maarten Rijks
par Bram Nijhof et Nick Strous
par plusieurs auteurs
par Dr. Lena Niehoff
par Alison Dennis et Dr. Manja Epping
par Victoria Hordern et Dr. Tim Schwarz
par Séverine Bouvy